Joseph Wiley

Joseph Wiley is the Chief Executive Officer of Gamida Cell Ltd., a cell therapy company focused on developing treatments for cancer.12 He assumed this role on June 18, 2024, following a restructuring transaction with Highbridge Capital Management.2

Professional Background

Dr. Wiley has an extensive background in the pharmaceutical and biotechnology industries:

• He founded Amryt Pharma and served as its CEO until the company's acquisition by Chiesi Farmaceutici in April 2023.3
• Prior to Amryt, he held positions as:
  • Principal at Sofinnova Ventures
  • Medical Director at Astellas Pharma
  • Neurologist

Current Role at Gamida Cell

As CEO of Gamida Cell, Dr. Wiley is responsible for:

• Leading the company's efforts to commercialize Omisirge® (omidubicel-onlv), a novel cell therapy for allogenic hematopoietic stem cell transplant.2
• Overseeing the company's operations, including research and development, manufacturing, and commercialization of cell therapeutics.2
• Working with hospitals across the U.S. to expand access to Omisirge for patients in need.2

Education and Location

Dr. Wiley received his education from Trinity College, Dublin.4 He is based in Ireland.4

Professional Network

On LinkedIn, Dr. Wiley has over 500 connections and can be found under the username "josephwiley".4